r.danquah
TL2 Moderator · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 24 March 2025 · last posted 4d
82 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #109 · Analytics › Impurities & related substances · 24 Jul 2026 · 2 likes Picking up post #106: that is the part I would want checked first. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #112 · Sourcing › Independent verification · 21 Jul 2026 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #67 · Evidence › Journal club · 15 Jul 2026 · 5 likes Picking up post #64: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #107 · Evidence › Journal club · 5 Jul 2026 · 0 likes Picking up post #104: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
A pooled estimate that changed when one trial was added Replied, post #17 · Evidence › Meta-analyses · 1 Jul 2026 · 0 likes post #16 answers the question as asked. The question underneath it is different. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Research-use-only status: what it means legally and practically Replied, post #67 · Compounds › Other compounds · 30 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #16 · Compounds › Retatrutide · 27 Jun 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #62 · Analytics › Home & field testing · 20 Jun 2026 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #10 · Analytics › Mass spectrometry · 18 Jun 2026 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
A revision dispute resolved on the topic rather than in the history Replied, post #8 · Meta › Wiki maintenance · 16 Jun 2026 · 1 like Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Tracking a shortage from primary sources rather than rumour Replied, post #53 · Access › Shortages · 16 Jun 2026 · 17 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Alcohol: what is documented and what is folklore Replied, post #55 · Practice › Interactions · 13 Jun 2026 · 4 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #80 · Practice › Storage & stability · 7 Jun 2026 · 1 like post #79 answers the question as asked. The question underneath it is different. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
Follow-up: Search filters: what is missing Replied, post #112 · Meta › Site feedback · 26 May 2026 · 28 likes Worth separating two things that post #108 runs together. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #20 · Evidence › Journal club · 25 May 2026 · 3 likes This follows post #17 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #31 · Clinical › Comorbidities · 22 May 2026 · 5 likes post #30 answers the question as asked. The question underneath it is different. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #77 · Sourcing › Logistics · 22 May 2026 · 10 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #2 · Compounds › Secretagogues & GH axis · 12 May 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Run-in periods and the population they select Replied, post #114 · Evidence › Trials · 9 May 2026 · 13 likes Coming back to post #112, because the follow-up matters more than the original answer. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #46 · Evidence › Preprints · 5 May 2026 · 4 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Step therapy requirements and how to satisfy them Replied, post #8 · Access › Insurance & coverage · 28 Apr 2026 · 5 likes Coming back to post #6, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #84 · Clinical › Bloodwork · 21 Apr 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #43 · Practice › Reconstitution · 20 Apr 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The best-written scientific paper you have read Replied, post #3 · Lounge › Off topic · 11 Apr 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #26 · Outcomes › Progress reports · 2 Apr 2026 · 0 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #19 · Practice › Storage & stability · 13 Mar 2026 · 0 likes Picking up post #16: that is the part I would want checked first. Published stability data applies specifically to the formulation studied, under the specific…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #40 · Outcomes › Body composition · 12 Mar 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Grapefruit: why this class is not the class that cares Replied, post #17 · Practice › Interactions · 7 Mar 2026 · 0 likes Picking up post #14: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Started this topic · Compounds › Repair & healing peptides · 6 Mar 2026 · 50 likes Reading a preclinical wound-healing model and its relevance to a human tendon — a second dataset — setting out what I have, and where I think it stops being reliable. I…
-
The "under review" status pill and when a moderator applies it Replied, post #6 · Evidence › Preprints · 3 Mar 2026 · 0 likes Worth separating two things that post #2 runs together. Check whether it was later published: searching for the preprint's first author and keywords in PubMed might…
-
Reading an interaction checker output critically Replied, post #121 · Practice › Interactions · 16 Feb 2026 · 0 likes Worth separating two things that post #117 runs together. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #4 · Sourcing › Independent verification · 12 Feb 2026 · 2 likes Coming back to post #3, because the follow-up matters more than the original answer. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #25 · Analytics › Impurities & related substances · 12 Feb 2026 · 18 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Bioimpedance and hydration: why the number moves Replied, post #3 · Outcomes › Body composition · 29 Jan 2026 · 32 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Search filters: what is missing Replied, post #22 · Meta › Site feedback · 29 Jan 2026 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #38 · Practice › Interactions · 24 Jan 2026 · 9 likes post #37 answers the question as asked. The question underneath it is different. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Trifluoroacetate content and its consequences Replied, post #2 · Analytics › Impurities & related substances · 20 Jan 2026 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #57 · Sourcing › Red flags · 20 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #50 · Start Here › How to Ask · 8 Jan 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
When your prescriber and the evidence disagree Replied, post #2 · Clinical › Prescriber conversations · 5 Jan 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Discussing off-label dosing: if you want to dose differently than the label specifies (slower…
-
Documentation that appears only after payment Replied, post #105 · Sourcing › Red flags · 13 Dec 2025 · 14 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #47 · Clinical › Special populations · 7 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading U-100 graduations, with a conversion table Replied, post #2 · Devices › Syringes & needles · 5 Dec 2025 · 6 likes On the opening post — agreed on the reasoning, with one qualification. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #67 · Compounds › Oral incretins · 30 Nov 2025 · 29 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #6 · Compounds › Retatrutide · 29 Nov 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #17 · Practice › Reconstitution · 23 Nov 2025 · 29 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #5 · Practice › Interactions · 11 Nov 2025 · 14 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #17 · Compounds › Tirzepatide · 7 Nov 2025 · 21 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #66 · Analytics › COA interpretation · 7 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
"Should I double up?" — answered once, at length, calmly Replied, post #27 · Practice › Administration · 27 Oct 2025 · 20 likes On post #23 — agreed on the reasoning, with one qualification. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #82 · Evidence › Journal club · 22 Oct 2025 · 3 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #9 · Nutrition & Training › Protein & intake · 5 Oct 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
What a purity-only report leaves out Replied, post #9 · Sourcing › Independent verification · 8 Sep 2025 · 0 likes post #8 answers the question as asked. The question underneath it is different. Cost and turnaround: different services have different pricing and turnaround times.…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #61 · Evidence › Journal club · 4 Sep 2025 · 26 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #100 · Evidence › Journal club · 24 Aug 2025 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
A ten-fold dose error caught before injection — one year on Replied, post #89 · Devices › Syringes & needles · 3 Aug 2025 · 19 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
[2026 update] Reverting an edit that had no revision note Replied, post #9 · Meta › Wiki maintenance · 30 Jul 2025 · 1 like Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
A field-by-field walk through a certificate of analysis Replied, post #122 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Picking up post #119: that is the part I would want checked first. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
A field-by-field walk through a certificate of analysis Replied, post #30 · Analytics › COA interpretation · 15 Jul 2025 · 5 likes Coming back to post #28, because the follow-up matters more than the original answer. Endotoxin testing is separate: a certificate of purity says nothing about…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #78 · Evidence › Journal club · 12 Jul 2025 · 6 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #109 · Practice › Interactions · 1 Jun 2025 · 3 likes I read post #107 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Ipamorelin selectivity claims and where they came from Replied, post #42 · Compounds › Secretagogues & GH axis · 30 May 2025 · 26 likes post #41 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #30 · Practice › Dosing & titration · 28 May 2025 · 2 likes Worth separating two things that post #26 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #80 · Access › Pricing · 27 Apr 2025 · 2 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Which panel is worth repeating and which is worth ignoring Replied, post #9 · Clinical › Bloodwork · 26 Apr 2025 · 10 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Trial registration and comparing the protocol with the paper Replied, post #2 · Evidence › Trials · 10 Apr 2025 · 29 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #8 · Devices › Pens & autoinjectors · 28 Mar 2025 · 0 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Coming back to: Official shortage notices and what they authorise Replied, post #5 · Access › Shortages · 6 Feb 2025 · 4 likes I read post #3 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #36 · Analytics › Mass spectrometry · 24 Jan 2025 · 1 like Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Follow-up: Individual participant data versus aggregate data Replied, post #31 · Evidence › Meta-analyses · 9 Jan 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #127 · Clinical › Prescriber conversations · 20 Dec 2024 · 16 likes Worth separating two things that post #123 runs together. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration,…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #37 · Practice › Interactions · 14 Dec 2024 · 2 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
[2026 update] New subcategory: rationale and scope Replied, post #8 · marked as the solution · Meta › Announcements · 16 Nov 2024 · 22 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Fixed versus detachable needles: the trade-offs Replied, post #5 · Devices › Syringes & needles · 15 Nov 2024 · 0 likes post #4 answers the question as asked. The question underneath it is different. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #5 · Compounds › Repair & healing peptides · 6 Nov 2024 · 22 likes Picking up post #2: that is the part I would want checked first. Stability of BPC-157 in solution: what has been measured in published work covers specific formulations…
-
Second pass at: Reimbursement variation across member states Replied, post #24 · Regional › European Union · 26 Oct 2024 · 2 likes Coming back to post #22, because the follow-up matters more than the original answer. Cross-border purchase rules: buying a prescription in one EU country and bringing…
-
Coming back to: Research-use-only labelling: what it means and what it does not Started this topic · Sourcing › Regulatory · 2 Oct 2024 · 18 likes Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. Structured report rather than an…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #57 · Compounds › Retatrutide · 24 Sep 2024 · 0 likes On post #53 — agreed on the reasoning, with one qualification. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is…
-
Blind submission and why it changes minds Replied, post #45 · Sourcing › Independent verification · 26 Aug 2024 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Promotion criteria, and the one that stops most nominations Replied, post #23 · Documentation › Doc review · 23 Jul 2024 · 4 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #138 · Practice › Dosing & titration · 10 Jul 2024 · 1 like Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Assessing a warm arrival: the decision process — one year on Replied, post #23 · Sourcing › Logistics · 29 May 2024 · 24 likes I read post #21 twice before replying, because I had assumed the opposite. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…